SORRENTINO, SABATO
 Distribuzione geografica
Continente #
NA - Nord America 2.509
AS - Asia 1.571
EU - Europa 747
SA - Sud America 218
Continente sconosciuto - Info sul continente non disponibili 204
AF - Africa 47
OC - Oceania 1
Totale 5.297
Nazione #
US - Stati Uniti d'America 2.371
SG - Singapore 623
IT - Italia 361
CN - Cina 346
BD - Bangladesh 192
BR - Brasile 173
IN - India 117
VN - Vietnam 109
DE - Germania 70
CA - Canada 61
HK - Hong Kong 60
NL - Olanda 54
GB - Regno Unito 50
RU - Federazione Russa 44
SE - Svezia 44
FI - Finlandia 36
MX - Messico 25
IL - Israele 21
FR - Francia 18
IQ - Iraq 18
SC - Seychelles 14
ZA - Sudafrica 14
AR - Argentina 12
ES - Italia 11
CR - Costa Rica 10
JP - Giappone 10
AT - Austria 9
CO - Colombia 9
ID - Indonesia 9
PK - Pakistan 9
PL - Polonia 9
TR - Turchia 9
UA - Ucraina 9
EC - Ecuador 8
CW - ???statistics.table.value.countryCode.CW??? 7
SV - El Salvador 7
PR - Porto Rico 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
CZ - Repubblica Ceca 5
JO - Giordania 5
MY - Malesia 5
NI - Nicaragua 5
RO - Romania 5
AE - Emirati Arabi Uniti 4
GT - Guatemala 4
HN - Honduras 4
KE - Kenya 4
LT - Lituania 4
PH - Filippine 4
PY - Paraguay 4
UY - Uruguay 4
VE - Venezuela 4
AZ - Azerbaigian 3
BE - Belgio 3
BH - Bahrain 3
CL - Cile 3
DZ - Algeria 3
ET - Etiopia 3
GP - Guadalupe 3
PT - Portogallo 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
CH - Svizzera 2
DK - Danimarca 2
EG - Egitto 2
IE - Irlanda 2
JM - Giamaica 2
MA - Marocco 2
NO - Norvegia 2
PA - Panama 2
TH - Thailandia 2
AW - Aruba 1
BB - Barbados 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
GR - Grecia 1
HT - Haiti 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
MN - Mongolia 1
NP - Nepal 1
NR - Nauru 1
OM - Oman 1
PE - Perù 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
Totale 5.100
Città #
San Jose 529
Singapore 266
Ashburn 257
Santa Clara 152
Chandler 108
Council Bluffs 108
Bengaluru 96
Hefei 94
Dallas 92
Beijing 72
Milan 65
Phoenix 65
Hong Kong 58
New York 49
Los Angeles 44
Munich 44
Chicago 40
Princeton 39
Ho Chi Minh City 37
Lawrence 37
Rome 32
London 27
Helsinki 22
Hanoi 21
São Paulo 21
Wilmington 21
Catanzaro 19
Amsterdam 17
Buffalo 15
Denver 15
Mexico City 14
Naples 14
Turku 14
Bologna 13
Brooklyn 11
Montreal 11
Assago 10
Atlanta 10
Boardman 10
Chennai 10
Ottawa 10
San Francisco 10
Haiphong 9
Johannesburg 9
Shanghai 9
Baghdad 8
Brescia 8
Des Moines 8
Orem 8
Stockholm 8
Tokyo 8
Bari 7
San José 7
San Salvador 7
Willemstad 7
Boston 6
Charlotte 6
Miami 6
Redmond 6
Tashkent 6
Toronto 6
Warsaw 6
Hanover 5
Jakarta 5
Managua 5
Manchester 5
Newark 5
Nuremberg 5
Palermo 5
Seattle 5
Abbeville 4
Augusta 4
Brasília 4
Cape Town 4
Da Nang 4
Erbil 4
Houston 4
Huntington 4
Las Vegas 4
Macaé 4
Madison 4
Nairobi 4
Olomouc 4
Orangeburg 4
Rio de Janeiro 4
Sorocaba 4
Verona 4
Addis Ababa 3
Amman 3
Ankara 3
Baku 3
Biên Hòa 3
Campinas 3
Chieti 3
Cosenza 3
Ferrara 3
Florence 3
Guangzhou 3
Guatemala City 3
Jacksonville 3
Totale 2.891
Nome #
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention 145
Risk of Bleeding in Elderly Patients Undergoing Transcatheter Aortic Valve Implantation or Surgical Aortic Valve Replacement 100
Empagliflozin prevents doxorubicin-induced myocardial dysfunction 94
Effect of valve design and anticoagulation strategy on 30‐day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial 90
Early hemodynamic impact of SGLT2 inhibitors in overweight cardiometabolic heart failure: beyond fluid offloading to vascular adaptation– a preliminary report 88
Hand Laser Perfusion Imaging to Assess Radial Artery Patency: A Pilot Study. 80
Indirect Comparison of the Efficacy and Safety of Alirocumab and Evolocumab: A Systematic Review and Network Meta-Analysis 79
B-Type Natriuretic Peptide as Biomarker of COVID-19 Disease Severity-A Meta-Analysis 77
Hindlimb Ischemia Impairs Endothelial Recovery and Increases Neointimal Proliferation in the Carotid Artery. 75
Multichannel Electrocardiograms Obtained by a Smartwatch for the Diagnosis of ST-Segment Changes 72
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials 70
Mir-16 Modulates Endothelial Dysfunction After Balloon Injury in a Rat Model of Chronic Peripheral Ischemia. 68
The duration of balloon inflation affects the luminal diameter of coronary segments after Bioresorbable Vascular Scaffolds deployment 67
Down-Regulation of miR-23/27/24 Clusters by TGF-beta 1 Signalling Induces Phenotypic Switching of Vascular Smooth Muscle Cells in vitro and in Response to Vascular Injury in vivo. 67
Dual anti-thrombotic treatment with direct anticoagulants improves clinical outcomes in patients with Atrial Fibrillation with ACS or undergoing PCI. A systematic review and meta-analysis 66
Incidence and outcomes of transient new-onset atrial fibrillation complicating acute coronary syndromes: results from a systematic review and meta-analysis 65
Incidence, Predictors, and Prognostic Impact of Neurologic Events After TAVR According to VARC-3 Criteria 65
Mechanical heart valves between myths and new evidence: a systematic review and meta-analysis 63
Corrigendum to “miR-125a-5p Modulates Phenotypic Switch of Vascular Smooth Muscle Cells by Targeting ETS-1” (J. Mol. Biol. Jun 16 2017; 429(12):1817–1828) (S002228361730222X) (10.1016/j.jmb.2017.05.008) 62
Flow-Responsive Noncoding RNAs in the Vascular System: Basic Mechanisms for the Clinician 62
Predictors of outcomes in patients with mitral regurgitation undergoing percutaneous valve repair 61
The Role of Mir-16 on Endothelial Dysfunction in Rat with Atherosclerotic Diet with a Chronic Model of Femoral Artery Occlusion and Carotid Balloon Injury. 60
Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement 60
Strategies to Minimize Access Site-related Complications in Patients Undergoing Transfemoral Artery Procedures with Large-bore Devices 59
Instantaneous wave-Free Ratio (iFR) and Gradient (iFG): new promising adenosine-independent alternative to fractional flow reserve. Preliminary results from the FORECAST Study. 59
New Antithrombotic Strategies and Coronary Stent Technologies for Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention 59
MicroRNA-1 Downregulation Increases Connexin 43 Displacement and Induces Ventricular Tachyarrhythmias in Rodent Hypertrophic Hearts. 58
Cellular and Molecular Mechanisms Underlying Tricuspid Valve Development and Disease 57
Percutaneous closure versus medical treatment in stroke patients with patent foramen ovale. A Systematic review and meta-analysis. 57
Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients 57
Calculated Serum Osmolality, Acute Kidney Injury, and Relationship to Mortality after Percutaneous Coronary Intervention 56
The instantaneous wave-Free Ratio (iFR) for evaluation of non culprit lesions in patients with Acute Coronary Syndrome and multivessel disease. 56
Delayed sudden radial artery rupture after left transradial coronary catheterization: a case report. 55
The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO‐3 trial 54
Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve implantation in patients without indications for chronic oral anticoagulation: a systematic review and network meta-analysis of randomized controlled trials 53
Acute expansion of nitinol-based self-expandable device in patients undergoing transfemoral aortic valve implantation 53
Determinants of Significant Out-Of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary Intervention 52
Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 52
Down-regulation of miR-23b induces phenotypic switching of vascular smooth muscle cells in vitro and in vivo 51
Small‐vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus‐eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post‐Approval studies 50
The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function 50
[Debate on dual pathway inhibition: Antiplatelet and anticoagulant therapies in patients undergoing percutaneous coronary intervention at high risk for recurrent ischemic events. Focus on anticoagulation-based strategies] 50
Direct Oral Anticoagulants in Patients With Active Cancer 50
Prediction of Significant Coronary Artery Disease Through Advanced Echocardiography: Role of Non-invasive Myocardial Work 50
Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study 49
Non-invasive myocardial work is reduced during transient acute coronary occlusion 49
Single Versus Dual Antiplatelet Therapy Following TAVR: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 49
Non-Invasive Myocardial Work in Patients with Severe Aortic Stenosis 48
White blood cell count and clinical outcomes after left main coronary artery revascularization: insights from the EXCEL trial 47
Acute Kidney Injury After Transcatheter Aortic Valve Replacement Mediates the Effect of Chronic Kidney Disease 47
Clinical and Procedural Outcomes of 5-French versus 6-French Sheaths in Transradial Coronary Interventions 46
Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention 45
Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor. 45
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction 44
Rationale for Early Administration of PCSK9 Inhibitors in Acute Coronary Syndrome 44
Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients for the Treatment of Severe Aortic Stenosis 44
Edwards SAPIEN Versus Medtronic Aortic Bioprosthesis in Women Undergoing Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry) 43
Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent Generation 43
The Telecardiology Revolution: From Emergency Management to Daily Clinical Practice 43
Effect of Transcatheter Aortic Valve Implantation on Non-Invasive Myocardial Work Parameters: A Systematic Review and Meta-Analysis 43
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk 43
Simultaneous Radial and Ipsilateral Ulnar Artery Compression versus Isolated Radial Artery Compression after Conventional Radial Access for Coronary Angiography and/or Intervention: A Systematic Review and Meta-Analysis 43
Effect of SGLT2 inhibitors on cardiac structure and function assessed by cardiac magnetic resonance: a systematic review and meta-analysis 42
Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta‐analysis 41
Exosomal microRNAs in heart disease 41
Cerebral Embolic Protection During TAVR 40
Stent Thrombosis After Percutaneous Coronary Intervention 40
Assessing and minimizing the risk of percutaneous coronary intervention in patients with chronic kidney disease 40
Reliability of Instantaneous Wave-Free Ratio (iFR) for the Evaluation of Left Main Coronary Artery Lesions 40
Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO‐3 randomized trial 39
Unmet Needs in TAVR: Conduction Disturbances and Management of Coronary Artery Disease 39
Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents 39
The link between anemia and adverse outcomes in patients with acute coronary syndrome 38
The prevalence, predictors and outcomes of guideline‐directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry 38
Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention—Results from the PROMETHEUS registry 38
Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age 37
Artificial Intelligence in Cardiac Electrophysiology: A Clinically Oriented Review with Engineering Primers 37
Stent Thrombosis After Percutaneous Coronary Intervention: From Bare-Metal to the Last Generation of Drug-Eluting Stents 37
Bioprosthetic leaflet thrombosis and reduced leaflet motion after transcatheter aortic valve replacement: A systematic review and meta-analysis 37
Impact of Baseline Atrial Fibrillation on Outcomes Among Women Who Underwent Contemporary Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry) 36
Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence 36
Reduction of hospitalisations and increased mortality for acute coronary syndromes during covid-19 era: Not all countries are equal 34
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention 34
Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention 34
Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry) 34
Standard Versus Ultrasound-Guided Cannulation of the Femoral Artery in Patients Undergoing Invasive Procedures: A Meta-Analysis of Randomized Controlled Trials 34
Common Calcified Femoral Artery Rupture After Intravascular Lithotripsy for TAVR Implantation 33
Temporal trends, determinants, and impact of high-intensity statin prescriptions after percutaneous coronary intervention 31
Impact of pre‐existing or new‐onset atrial fibrillation on 30‐day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial 31
Clinical manifestations and outcomes of coronavirus disease‐19 in heart transplant recipients: a multicentre case series with a systematic review and meta‐analysis 29
Sex‐Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient‐Level Pooled Analysis From 4 Postapproval Studies 29
Feasibility of measuring patient-reported health status at time of percutaneous coronary intervention: Results from a single-center quality-improvement initiative 29
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry) 29
Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies 28
Drug-coated balloons and hybrid strategies versus drug-eluting stents in chronic total occlusions: a systematic review and meta-analysis 27
Arrhythmias in Pediatric Age: A Narrative Review 27
Clinical Outcomes in Atrial Fibrillation Patients Undergoing Transcatheter Aortic Valve Replacement With Contemporary Devices 27
Vascular Complications in Patients Undergoing Transcatheter Aortic Valve Replacement With Contemporary Devices 26
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry 25
Early safety after TAVR according to VARC-3 criteria: incidence, predictors, and clinical impact 25
Totale 4.990
Categoria #
all - tutte 42.280
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.280


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202289 0 0 0 0 11 4 0 28 12 13 18 3
2022/2023370 80 12 40 13 48 29 3 27 57 21 31 9
2023/2024236 29 23 12 12 3 43 0 13 64 5 18 14
2024/2025848 102 35 35 23 60 138 43 16 82 17 117 180
2025/20262.706 100 243 162 288 300 108 316 136 337 221 318 177
2026/2027903 33 141 372 259 98 0 0 0 0 0 0 0
Totale 5.297